Published in Intensive Care Med on January 01, 1990
Impact of digestive and oropharyngeal decontamination on the intestinal microbiota in ICU patients. Intensive Care Med (2010) 1.18
Comparative gut microbiota and resistome profiling of intensive care patients receiving selective digestive tract decontamination and healthy subjects. Microbiome (2017) 0.75
Prophylactic use of the new quinolones for prevention of nosocomial infection in the intensive care unit. Drugs (1995) 0.75
Fifteen years of clinical liver transplantation. Gastroenterology (1979) 7.19
Colonization resistance of the digestive tract in conventional and antibiotic-treated mice. J Hyg (Lond) (1971) 7.03
Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine (Baltimore) (1988) 5.77
Successful chemoprophylaxis for Pneumocystis carinii pneumonitis. N Engl J Med (1977) 3.97
Bacterial translocation and gram-negative bacteremia in patients with hematological malignancies. J Infect Dis (1985) 2.69
The effect of selective decontamination of the digestive tract on colonisation and infection rate in multiple trauma patients. Intensive Care Med (1984) 2.60
Risk factors for pneumonia and fatality in patients receiving continuous mechanical ventilation. Am Rev Respir Dis (1986) 2.04
Colonization resistance of the digestive tract: clinical consequences and implications. J Antimicrob Chemother (1982) 1.87
Determination of the colonization resistance of the digestive tract of individual mice. J Hyg (Lond) (1974) 1.72
Infection prevention in granulocytopenic patients by selective decontamination of the digestive tract. Eur J Cancer (1980) 1.52
Infection by the distribution of biotypes of enterobacteriacease species in leukaemic patients treated under ward conditions and in units for protective isolation in seven hospitals in Europe. Infection (1977) 1.49
Infectious complications in heart-lung transplant recipients. Am J Med (1985) 1.40
Bacteriological aspects of selective decontamination of the digestive tract as a method of infection prevention in granulocytopenic patients. Antimicrob Agents Chemother (1981) 1.37
Risk factors for postoperative pneumonia. The importance of protein depletion. Ann Surg (1988) 1.35
Norfloxacin binds to human fecal material. Antimicrob Agents Chemother (1988) 1.25
Opportunistic infections in severely burned patients. Am J Med (1984) 1.21
Analysis of late infections in 89 long-term survivors of bone marrow transplantation. Blood (1979) 1.21
Bacterial interference by oropharynegeal and clinical isolates of anaerobic bacteria. J Infect Dis (1976) 1.15
Selective suppression of alimentary tract microbial flora as prophylaxis during granulocytopenia. Antimicrob Agents Chemother (1981) 1.13
Biological inactivation by faeces of antimicrobial drugs applicable in selective decontamination of the digestive tract. J Antimicrob Chemother (1984) 1.02
Efficiency of intensive care. A comparative analysis of eight pediatric intensive care units. JAMA (1987) 1.00
Evidence of immunoregulation of the composition of intestinal microflora and its practical consequences. Eur J Clin Microbiol Infect Dis (1988) 0.96
Escherichia coli serotypes in the faeces of healthy adults over a period of several months. J Hyg (Lond) (1977) 0.95
Selective bowel decontamination to decrease gram-negative aerobic bacterial and Candida colonization and prevent infection after orthotopic liver transplantation. Transplantation (1988) 0.94
A survey of infection in an intensive care unit. "Forewarned is forearmed". Anaesthesia (1980) 0.88
Bacterial interference by anaerobic species isolated from human feces. Eur J Clin Microbiol (1987) 0.88
Ciprofloxacin and norfloxacin for selective decontamination in patients with severe granulocytopenia. Infection (1988) 0.86
Bone marrow transplantation for acute myelogenous leukemia. Factors associated with early mortality. JAMA (1983) 0.86
Selective decontamination of alimentary tract microbial flora in patients treated with bone marrow transplantation. A microbiological study. Scand J Infect Dis (1984) 0.86
Selective intestinal decontamination of the digestive tract for infection prophylaxis in severely burned patients. Scand J Plast Reconstr Surg Hand Surg (1987) 0.85
Enzymatic inactivation of aztreonam by faecal enzyme preparations from healthy volunteers. Infection (1987) 0.85
Genitourinary infections in the patient at risk: extrinsic risk factors. Am J Med (1984) 0.84
Randomized controlled trial comparing trimethoprim/sulfamethoxazole and trimethoprim for infection prophylaxis in hospitalized granulocytopenic patients. Am J Med (1984) 0.84
Trimethoprim used for selective decontamination of the digestive tract in rats: possible route of excretion. Scand J Infect Dis (1987) 0.83
Prevention of infection in acute leukemia: a prospective randomized study on the efficacy of two different drug regimens for antimicrobial prophylaxis. Infection (1987) 0.82
Colistin and trimethoprim-sulfamethoxazole for the prevention of infection in patients with acute non-lymphocytic leukaemia. Decrease in the emergence of resistant bacteria. Infection (1983) 0.81
Symposium on infectious complications of neoplastic disease (Part II). Chemoprophylaxis of bacterial infections in granulocytopenic patients. Am J Med (1984) 0.81
Serious wound infections in burned patients. Surgery (1985) 0.80
Polymicrobial septicemia in the cancer patient. Medicine (Baltimore) (1986) 0.80
Selective decontamination of the digestive tract with oral aztreonam and temocillin. Rev Infect Dis (1986) 0.78
Concentrations of amphotericin B in faeces and blood of healthy volunteers after the oral administration of various doses. Infection (1982) 0.76
Autologous bone marrow transplantation. Annu Rev Med (1989) 0.76
Antimicrobial prophylaxis in neutropenic patients after bone marrow transplantation. Infection (1988) 0.75
Amphotericin B concentrations in saliva after application of 2% amphotericin B in orabase. Infection (1978) 0.75
The role of autologous bone marrow transplantation in various malignancies. Semin Hematol (1984) 0.75
Salivary concentrations of amphotericin B following its use as an oral lozenge. Infection (1980) 0.75
Selective decontamination of the digestive tract in hepatobiliary surgery: a concept. HPB Surg (1990) 0.75
Decontamination of the digestive tract and oropharynx in ICU patients. N Engl J Med (2009) 8.30
Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis. Ann Intern Med (1994) 2.62
Differences in virulence between two strains of Streptococcus suis type II after experimentally induced infection of newborn germ-free pigs. Am J Vet Res (1989) 2.56
Mapping the pathways to staphylococcal pathogenesis by comparative secretomics. Microbiol Mol Biol Rev (2006) 1.93
The release of endotoxin from antibiotic-treated Escherichia coli and the production of tumour necrosis factor by human monocytes. J Antimicrob Chemother (1993) 1.77
The ecology of the human intestine and its consequences for overgrowth by pathogens such as Clostridium difficile. Annu Rev Microbiol (1989) 1.70
Infection prevention in granulocytopenic patients by selective decontamination of the digestive tract. Eur J Cancer (1980) 1.52
Carrier rate of Streptococcus suis capsular type 2 in palatine tonsils of slaughtered pigs. J Clin Microbiol (1984) 1.49
[Meningitis after a superficial dog bite]. Ned Tijdschr Geneeskd (2002) 1.45
Effects of different types and combinations of antimicrobial agents on endotoxin release from gram-negative bacteria: an in-vitro and in-vivo study. Scand J Infect Dis (1991) 1.45
Bacteriological aspects of selective decontamination of the digestive tract as a method of infection prevention in granulocytopenic patients. Antimicrob Agents Chemother (1981) 1.37
Selective decontamination of the digestive tract with aztreonam: a study of 10 healthy volunteers. J Infect Dis (1984) 1.21
Campylobacter species isolated from extra-oro-intestinal abscesses: a report of four cases and literature review. Eur J Clin Microbiol Infect Dis (2008) 1.12
Patterns of cytokines, plasma endotoxin, plasminogen activator inhibitor, and acute-phase proteins during the treatment of severe sepsis in humans. Crit Care Med (1992) 1.11
Ochrobactrum intermedium infection after liver transplantation. J Clin Microbiol (1999) 1.06
Spread of a methicillin-resistant Staphylococcus aureus ST80 strain in the community of the northern Netherlands. Eur J Clin Microbiol Infect Dis (2007) 1.03
Evidence of immunoregulation of the composition of intestinal microflora and its practical consequences. Eur J Clin Microbiol Infect Dis (1988) 0.96
The effect of ceftriaxone on the anaerobic bacterial flora and the bacterial enzymatic activity in the intestinal tract. Infection (1992) 0.91
The influence of antibiotics on gut colonization. J Antimicrob Chemother (1986) 0.91
Staphylococcal acid phosphatase binds to endothelial cells via charge interaction; a pathogenic role in Wegener's granulomatosis? Clin Exp Immunol (2000) 0.86
Oral mucositis and selective elimination of oral flora in head and neck cancer patients receiving radiotherapy: a double-blind randomised clinical trial. Br J Cancer (2003) 0.85
Enzymatic inactivation of aztreonam by faecal enzyme preparations from healthy volunteers. Infection (1987) 0.85
History of recognition and measurement of colonization resistance of the digestive tract as an introduction to selective gastrointestinal decontamination. Epidemiol Infect (1992) 0.85
Problems and priorities for controlling opportunistic pathogens with new antimicrobial strategies; an overview of current literature. Zentralbl Bakteriol (1996) 0.84
Is bacteriologic surveillance in endoscope reprocessing stringent enough? Endoscopy (2009) 0.84
Ciprofloxacin for cholangitis after hepatic portoenterostomy. Lancet (1987) 0.83
Latent introduction to the Netherlands of multiple antibiotic resistance including NDM-1 after hospitalisation in Egypt, August 2013. Euro Surveill (2013) 0.82
Prevention of infection in acute leukemia: a prospective randomized study on the efficacy of two different drug regimens for antimicrobial prophylaxis. Infection (1987) 0.82
Enteral nutrition by nasogastric tube in adult patients treated with intensive chemotherapy for acute leukemia. Am J Clin Nutr (1982) 0.82
An intrarenal abscess as presenting symptom of an infection with Nocardia farcinica in a patient after renal transplantation. Transpl Infect Dis (2007) 0.80
A prospective, randomized, double-blinded, placebo-controlled trial of empirical teicoplanin in febrile neutropenia with persistent fever after imipenem monotherapy. J Antimicrob Chemother (2000) 0.79
Tolerance and efficacy of Amphotericin B inhalations for prevention of invasive pulmonary aspergillosis in haematological patients. Eur J Clin Microbiol Infect Dis (1997) 0.79
Selective decontamination of the digestive tract prevents secondary infection of the abdominal cavity, and endotoxemia and mortality in sterile peritonitis in laboratory rats. Crit Care Med (1992) 0.79
Inactivation of ceftriaxone by faecal enzyme preparations during ceftriaxone treatment. J Antimicrob Chemother (1992) 0.79
Vaginal hysterectomy: cefuroxime, metronidazole or both? Pharm Weekbl Sci (1990) 0.78
Bacterial translocation in D-galactosamine-treated rats in a burn model. Burns (1996) 0.78
[An adenovirus epidemic in patients with kidney transplantation]. Ned Tijdschr Geneeskd (1991) 0.78
Risk factors for colonization with enterococci in a neonatal intensive care unit. Clin Microbiol Infect (2000) 0.78
Patterns of cytokines, plasma endotoxin, and acute phase proteins during the treatment of severe sepsis in humans. Prog Clin Biol Res (1991) 0.78
The efficacy of selective bowel decontamination as infection prevention after liver transplantation. Transplant Proc (1990) 0.78
Prevention of infection in acute leukemia. Haematol Blood Transfus (1990) 0.77
Colonization resistance of the digestive tract; mechanism and clinical consequences. Ann Ist Super Sanita (1986) 0.77
Multicentre in-vitro evaluation of the susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis to ciprofloxacin, clarithromycin, co-amoxiclav and sparfloxacin. J Antimicrob Chemother (1997) 0.77
Tissue reactions to bacteria-challenged implantable leads with enhanced infection resistance. J Biomed Mater Res (1998) 0.77
Complement activation and the production of inflammatory mediators during the treatment of severe sepsis in humans. Scand J Infect Dis (1992) 0.76
Concentrations of amphotericin B in faeces and blood of healthy volunteers after the oral administration of various doses. Infection (1982) 0.76
Does the empiric use of vancomycin in pediatrics increase the risk for Gram-negative bacteremia? Pediatr Infect Dis J (2001) 0.76
[Three infants with constipation and muscular weakness: infantile botulism]. Ned Tijdschr Geneeskd (2005) 0.75
Incidence and effects of herpes simplex virus infection after autologous bone marrow transplantation for solid tumours. Neth J Med (1989) 0.75
Amphotericin B concentrations in saliva after application of 2% amphotericin B in orabase. Infection (1978) 0.75
[Optimalization of antibiotic policy in the Netherlands. VII. SWAB-guidelines for antimicrobial therapy in adult patients with infectious endocarditis]. Ned Tijdschr Geneeskd (2004) 0.75
Failure of an automated blood culture system to detect nonfermentative gram-negative bacteria. J Clin Microbiol (2000) 0.75
Concentrations of nystatin in faeces after oral administration of various doses of nystatin. Infection (1979) 0.75
Clinical and bacteriological efficacy and tolerability of FCE 22891 in patients with exacerbations of chronic obstructive pulmonary disease. Antimicrob Agents Chemother (1994) 0.75
The effect of amphotericin B lozenges on the presence and number of Candida cells in the oropharynx of neutropenic leukemia patients. Infection (1982) 0.75
Comparison of imipenem versus cefuroxime plus tobramycin as empirical therapy for febrile granulocytopenic patients and efficacy of vancomycin and aztreonam in case of failure. Scand J Infect Dis (1994) 0.75
Endotoxin in paroxysmal nocturnal haemoglobulinuria (PNH) Br J Haematol (1982) 0.75
Rationale for use of beta-aspartylglycine as indicator of colonization resistance. Prog Clin Biol Res (1985) 0.75
The microflora of the gut: recent findings and implications. Dig Dis (1991) 0.75
[Bacteremia caused by Streptococcus salivarius and S. Milleri, and colonic carcinoma]. Ned Tijdschr Geneeskd (1994) 0.75
The role of systemic antibodies against intestinal Escherichia coli in the prevention of bacterial translocation of Escherichia coli in a burn model in mice. J Trauma (1994) 0.75
Low-dose ciprofloxacin for selective decontamination of the digestive tract in human volunteers. Eur J Clin Microbiol Infect Dis (1990) 0.75
[Problems concerning the diagnosis of actinomycosis]. Ned Tijdschr Geneeskd (1991) 0.75
Improvement of bleeding time, platelet aggregation and platelet count during CAPD treatment. Proc Eur Dial Transplant Assoc (1981) 0.75
Successful medical treatment of multiple Serratia marcescens brain abscesses in a neonate. Eur J Pediatr (1996) 0.75
Salivary concentrations of amphotericin B following its use as an oral lozenge. Infection (1980) 0.75
Burden of highly resistant microorganisms in a Dutch intensive care unit. Neth J Med (2015) 0.75
[Intestinal perforation caused by tuberculosis in a kidney transplant patient who was extensively evaluated for tuberculosis prior to transplant]. Ned Tijdschr Geneeskd (2006) 0.75
Applicability of random primer R143 for determination of Aspergillus fumigatus DNA. J Med Vet Mycol (1998) 0.75
[Diagnostic image (105). A woman with painful nodules. Infection with O. volvulus]. Ned Tijdschr Geneeskd (2002) 0.75
Selective decontamination of the digestive tract: general principles. Eur J Cancer Clin Oncol (1988) 0.75
Effect of polymyxin B on intestinal bacterial translocation in Pseudomonas aeruginosa wound-colonized burned mice. Eur Surg Res (1992) 0.75
High-dose cyclophosphamide and high-dose VP 16-213 for recurrent or refractory small cell lung cancer. A phase II study. Eur J Cancer Clin Oncol (1985) 0.75
Faecal endotoxin and activity of the gut-associated lymphoid tissue in patients with malignant (B-cell) lymphoma. Zentralbl Bakteriol Mikrobiol Hyg A (1985) 0.75
[Current bronchoscopic techniques in the diagnosis of various forms of pneumonia]. Ned Tijdschr Geneeskd (1994) 0.75
[Choice of antimicrobial therapy for Legionnella infection]. Ned Tijdschr Geneeskd (2005) 0.75
An unusual presentation of sepsis caused by coagulase-negative staphylococci. Neth J Med (1999) 0.75
[A complicated varicella infection]. Ned Tijdschr Geneeskd (1990) 0.75
Bacteriological data on a prospective multicenter study of the effect of two different regimens for selective decontamination in patients with acute leukaemia. Infection (1987) 0.75